DXCM Stock Price, Chart, Stats & News

DexCom, Inc.
Save
26.93B
Market cap
29.95x
Current P/E
28.33x
Forward P/E
DXCM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 60.10% |
Operating margin | 19.56% |
Pretax margin | 23.35% |
Net margin | 17.94% |
Effective tax rate | 23.16% |
ROA | 13.19% |
ROE | 32.44% |
D/E | 0.51x |
Interest coverage ratio | 64.67x |
DXCM valuation
P/E | 29.95x |
P/S | 5.21x |
P/B | 8.77x |
P/CF | 16.71x |
P/FCF | 22.54x |
P/OCF | 16.71x |
PEG | 1.78x |
EV multiple | 17.81x |
About
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform.
Similar securities
Based on sector and market capitalization
Report issue











